| Dr William F Hineser, DPM | |
|
7375 W 52nd Ave Ste 350, Arvada, CO 80002-3702 | |
| (303) 421-3668 | |
| (303) 424-0163 |
| Full Name | Dr William F Hineser |
|---|---|
| Gender | Male |
| Speciality | Podiatrist |
| Location | 7375 W 52nd Ave Ste 350, Arvada, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619972312 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 00268 (Colorado) | Secondary |
| 213E00000X | Podiatrist | 268 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr William F Hineser, DPM 7375 W 52nd Ave Ste 350, Arvada, CO 80002-3702 Ph: (303) 421-3668 | Dr William F Hineser, DPM 7375 W 52nd Ave Ste 350, Arvada, CO 80002-3702 Ph: (303) 421-3668 |
News Archive
The Global Health Innovative Technology Fund (GHIT Fund), a new public health partnership that is bringing Japanese know-how and investment to the global fight against infectious diseases, announced today grants of US$5.7 million to six global partnerships working on innovative drugs and vaccines against malaria, tuberculosis and Chagas disease.
Celgene International Sàrl today announced results from a phase II investigator initiated study of REVLIMID (lenalidomide) in combination with Avastin (bevacizumab), docetaxel and prednisone in patients with metastatic castration-resistant prostate cancer were presented at the 2011 American Society of Clinical Oncology Annual Meeting in Chicago, Ill.
The appearance of a deadly new strain of tuberculosis (TB) has so concerned the World Health Organisation (WHO) that an emergency meeting of health experts has been convened in Johannesburg to discuss the issue.
Gilead Sciences, Inc. today announced it is stopping ARTEMIS-IPF, the company's ongoing Phase III clinical trial of ambrisentan in patients with idiopathic pulmonary fibrosis (IPF), due to lack of efficacy. This decision follows an interim analysis of unblinded efficacy and safety data by the study's Data Monitoring Committee (DMC) and review of those data by Gilead, which did not show evidence of a treatment benefit in the group of patients randomized to receive ambrisentan.
The Asia-Pacific region faces a number of challenges in preparing for an influenza pandemic, yet gaps and inconsistencies in plans across the continent could hinder an effective response to a pandemic, according to a new report presented at the Lancet Asia Medical Forum 2006, Singapore.
› Verified 2 days ago
Arvada Foot And Ankle Pllc Podiatrist Medicare: Medicare Enrolled Practice Location: 5730 Ward Rd Ste 202, Arvada, CO 80002 Phone: 720-390-5299 | |
Foothealth Pc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 7375 W 52nd Ave, Suite 350, Arvada, CO 80002 Phone: 303-421-3668 Fax: 303-425-0163 | |
James S Scales Pc Inc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 7375 W 52nd Ave, Suite 350, Arvada, CO 80002 Phone: 303-421-3668 | |
Dr. Luc Bibeau, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 5730 Ward Rd Ste 202, Arvada, CO 80002 Phone: 720-390-5299 Fax: 203-685-1757 | |
James S Scales, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 7375 W 52nd Ave, Suite 350, Arvada, CO 80002 Phone: 303-421-3668 Fax: 303-425-0163 |